David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVMI
3326
PUT
Nova
NVMI
$11.7B
| $553K | ﹤0.01% |
+3,000
| New | +$693K |
|
3327
iShares Global Infrastructure ETF
IGF
$10.6B
| $550K | ﹤0.01% |
10,052
-7,051
| -41% | -$378K |
|
3328
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$291M
| $548K | ﹤0.01% |
13,232
| – | – |
|
3329
CALL
PagerDuty
PD
$945M
| $548K | ﹤0.01% |
30,000
| – | – |
|
3330
Vera Bradley
VRA
$91M
| $548K | ﹤0.01% |
243,482
-40,992
| -14% | -$132K |
|
3331
CALL
Thermo Fisher Scientific
TMO
$232B
| $547K | ﹤0.01% |
1,100
-9,700
| -90% | -$5.25M |
|
3332
Sensata Technologies
ST
$6.14B
| $546K | ﹤0.01% |
22,496
-369,588
| -94% | -$10.2M |
|
3333
CALL
Polaris
PII
$3.62B
| $545K | ﹤0.01% |
+13,300
| New | +$633K |
|
3334
Utah Medical Products
UTMD
$226M
| $544K | ﹤0.01% |
9,708
| – | – |
|
|
PDS
3335
Precision Drilling
PDS
$1.12B
| $544K | ﹤0.01% |
11,700
-27,800
| -70% | -$1.51M |
|
3336
iShares MSCI USA Equal Weighted ETF
EUSA
$1.95B
| $543K | ﹤0.01% |
5,804
| – | – |
|
3337
PUT
St. Joe Company
JOE
$3.96B
| $540K | ﹤0.01% |
11,500
| – | – |
|
|
BLFY
3338
DELISTED
Blue Foundry Bancorp
BLFY
| $539K | ﹤0.01% |
58,585
+9,383
| +19% | +$89.6K |
|
3339
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.31B
| $538K | ﹤0.01% |
+2,424
| New | +$597K |
|
|
HTB
3340
HomeTrust Bancshares
HTB
$771M
| $538K | ﹤0.01% |
15,703
+4,512
| +40% | +$159K |
|
3341
Northrim BanCorp
NRIM
$568M
| $538K | ﹤0.01% |
+29,404
| New | +$583K |
|
3342
CALL
MarineMax
HZO
$1.15B
| $538K | ﹤0.01% |
25,000
-21,600
| -46% | -$577K |
|
3343
Toll Brothers
TOL
$13.9B
| $535K | ﹤0.01% |
5,069
+2,700
| +114% | +$324K |
|
3344
Cytokinetics
CYTK
$10.8B
| $535K | ﹤0.01% |
+13,302
| New | +$611K |
|
3345
Allient
ALNT
$1.58B
| $534K | ﹤0.01% |
24,307
-82,762
| -77% | -$2.05M |
|
3346
AMERISAFE
AMSF
$485M
| $534K | ﹤0.01% |
+10,165
| New | +$515K |
|
3347
Editas Medicine
EDIT
$504M
| $533K | ﹤0.01% |
459,700
+280,185
| +156% | +$412K |
|
3348
Cass Information Systems
CASS
$734M
| $532K | ﹤0.01% |
+12,290
| New | +$522K |
|
3349
CALL
GeneDx Holdings
WGS
$2.61B
| $531K | ﹤0.01% |
6,000
+3,100
| +107% | +$269K |
|
3350
CALL
ChargePoint
CHPT
$151M
| $531K | ﹤0.01% |
43,900
-30,795
| -41% | -$513K |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.